vs
Side-by-side financial comparison of Massimo Group (MAMO) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Massimo Group is the larger business by last-quarter revenue ($21.0M vs $20.6M, roughly 1.0× Entrada Therapeutics, Inc.). Massimo Group runs the higher net margin — 9.5% vs -84.4%, a 93.9% gap on every dollar of revenue. On growth, Massimo Group posted the faster year-over-year revenue change (15.7% vs -65.2%). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -16.5%).
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
MAMO vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.0M | $20.6M |
| Net Profit | $2.0M | $-17.3M |
| Gross Margin | 41.5% | — |
| Operating Margin | 13.1% | -106.0% |
| Net Margin | 9.5% | -84.4% |
| Revenue YoY | 15.7% | -65.2% |
| Net Profit YoY | 215.0% | -173.8% |
| EPS (diluted) | $0.05 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.0M | — | ||
| Q3 25 | $17.0M | — | ||
| Q2 25 | $18.9M | — | ||
| Q1 25 | $14.9M | $20.6M | ||
| Q4 24 | $18.2M | $37.4M | ||
| Q3 24 | $25.6M | $19.6M | ||
| Q2 24 | $35.4M | $94.7M | ||
| Q1 24 | $30.2M | $59.1M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $77.7K | — | ||
| Q1 25 | $-2.1M | $-17.3M | ||
| Q4 24 | $-1.7M | $1.1M | ||
| Q3 24 | $-2.5M | $-14.0M | ||
| Q2 24 | $2.8M | $55.0M | ||
| Q1 24 | $3.2M | $23.5M |
| Q4 25 | 41.5% | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 27.2% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 34.7% | — |
| Q4 25 | 13.1% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | -18.2% | -106.0% | ||
| Q4 24 | -15.4% | -15.7% | ||
| Q3 24 | 1.2% | -110.7% | ||
| Q2 24 | 10.1% | 56.4% | ||
| Q1 24 | 13.2% | 35.7% |
| Q4 25 | 9.5% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | -14.0% | -84.4% | ||
| Q4 24 | -9.5% | 3.0% | ||
| Q3 24 | -9.8% | -71.7% | ||
| Q2 24 | 8.0% | 58.1% | ||
| Q1 24 | 10.6% | 39.7% |
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.04 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $-0.05 | $-0.42 | ||
| Q4 24 | $-0.05 | $-0.20 | ||
| Q3 24 | $-0.06 | $-0.35 | ||
| Q2 24 | $0.07 | $1.55 | ||
| Q1 24 | $0.08 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.8M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.7M | $417.3M |
| Total Assets | $51.4M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | — | ||
| Q3 25 | $2.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $3.0M | $67.8M | ||
| Q4 24 | $10.2M | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M |
| Q4 25 | $23.7M | — | ||
| Q3 25 | $21.7M | — | ||
| Q2 25 | $20.2M | — | ||
| Q1 25 | $19.9M | $417.3M | ||
| Q4 24 | $21.7M | $428.7M | ||
| Q3 24 | $22.5M | $422.4M | ||
| Q2 24 | $24.7M | $429.9M | ||
| Q1 24 | $18.1M | $269.4M |
| Q4 25 | $51.4M | — | ||
| Q3 25 | $44.4M | — | ||
| Q2 25 | $45.9M | — | ||
| Q1 25 | $46.4M | $486.5M | ||
| Q4 24 | $54.9M | $526.3M | ||
| Q3 24 | $57.1M | $554.6M | ||
| Q2 24 | $49.9M | $582.0M | ||
| Q1 24 | $47.3M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-38.5M |
| Free Cash FlowOCF − Capex | — | $-39.7M |
| FCF MarginFCF / Revenue | — | -192.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 2.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | — | ||
| Q3 25 | $633.2K | — | ||
| Q2 25 | $-1.4M | — | ||
| Q1 25 | $-3.3M | $-38.5M | ||
| Q4 24 | $9.1M | $-31.6M | ||
| Q3 24 | $4.7M | $-24.3M | ||
| Q2 24 | $-6.5M | $39.8M | ||
| Q1 24 | $-637.0K | $-25.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-39.7M | ||
| Q4 24 | $9.0M | $-32.2M | ||
| Q3 24 | $4.6M | $-24.9M | ||
| Q2 24 | $-6.7M | $38.8M | ||
| Q1 24 | $-741.4K | $-26.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -192.9% | ||
| Q4 24 | 49.7% | -86.2% | ||
| Q3 24 | 18.1% | -127.3% | ||
| Q2 24 | -19.0% | 41.0% | ||
| Q1 24 | -2.5% | -44.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | 0.2% | 1.7% | ||
| Q3 24 | 0.3% | 3.3% | ||
| Q2 24 | 0.7% | 1.1% | ||
| Q1 24 | 0.3% | 1.4% |
| Q4 25 | 2.01× | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | -17.92× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.30× | 0.72× | ||
| Q1 24 | -0.20× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
